摘要
Abstract
Objective To observe the clinical effect of Lifei decoction combined with budesonide and formoterol fumarate in the treatment of chronic obstructive pulmonary disease and its effect on pulmonary function.Methods Using the random number table method,totally 100 patients with chronic obstructive pulmonary disease diagnosed and treated in our hospital from November 2022 to June 2024 were divided into two groups,namely conventional group and study group,50 patients per group.The conventional group was treated with budesonide and formoterol fumarate,and the study group was treated with budesonide and formoterol fumarate+Lifei decoction.The therapeutic effect,pulmonary function indexes[forced vital capacity(FVC),maximum ventilation volume(MVV),forced expiratory volume in first second(FEV1)],TCM syndrome score,CAT score,mMRC score,blood gas index[partial pressure of oxygen(PaO2),partial pressure of carbon dioxide(PaCO2)]were compared between the two groups.Results Compared with the total effective rate of 84.00%in the conventional group,the total effective rate of the study group was higher,reaching 96.00%(P<0.05).In terms of lung function indexes,TCM syndrome score,CAT score,mMRC score and blood gas indexes,the study group had higher FVC,MVV,FEV1 and PaO2 after treatment than those in the conventional group,and lower TCM syndrome score,CAT score,mMRC score and PaCO2 than those in the conventional group(P<0.05).Conclusion The combination of Lifei decoction and budesonide and formoterol fumarate in the treatment of chronic obstructive pulmonary disease has an ideal clinical effect,which can promote the recovery of pulmonary function,improve respiratory status,reduce clinical symptoms,and effectively control the disease.It is worthy of clinical application.关键词
理肺汤/布地奈德福莫特罗/慢性阻塞性肺疾病/肺功能Key words
Lifei decoction/Budesonide and formoterol fumarate/Chronic obstructive pulmonary disease/Pulmonary function分类
医药卫生
